Project Overview 

Analyze and interpret bulk RNA sequencing data from patient biopsies/blood samples collected at baseline and post-treatment to identify therapeutic mechanisms, biomarkers of response, and potential side effects.

Services Provided

• Identify significantly DEGs post-treatment (paired/unpaired design) using DESeq2 or edgeR. 
• Identify significantly altered biological pathways (e.g. REACTOME) following treatment using GSEA or CAMERA.
• Identify clusters of highly correlated genes and relate them to clinical outcomes using WGCNA.

Deliverables & Benefits

• Comprehensive report detailing the findings.
• Mechanism of Action elucidation.
• Biomarker discovery: identify stable findings to stratify patients.
• Reproducibility: transparent and easy to reuse codebase.

Why Choose Lucid Analytics? 

With a deep understanding of life sciences and cutting-edge AI expertise, Lucid Analytics supports clients in accelerating innovation and driving impactful R&D outcomes.

Ready to Transform Your Data? 

Interested in how we can help with your next project? Contact us today to explore how data can drive your R&D success.